Get the Weekly Intelligence Brief — top committee picks every Sunday.
SRRK · NASDAQ · STOCK

Scholar Rock Holding Corporation

Healthcare Updated August 11, 2026
$52.11
52W $27.07 – $58.49
57/100
$6.24B
-15.7
0.67
AI Committee Verdict
Watch
57/100
Conviction: Contested · 60% agreement · 5 analysts
Contested

Is SRRK Bullish or Bearish?

Mixed. Innellis AI committee rates Scholar Rock Holding Corporation (SRRK) Watch with a composite score of 57/100 , based on 5 analysts with 60% agreement. Last updated August 11, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +2.77 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -17.23 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 18.2% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • Price-to-book of 18.3x prices in significant intangible value — Value
  • ROE of only -159.1% -- cheap may mean cheap for a reason — Value
  • Bollinger bandwidth of 18.2% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 11, 2026
Overall Committee Score
57/100
Agreement
60%
Analysts
5
Conviction
Contested
Sector Rank
Top 68%
of 192 Healthcare peers
Value Analyst neutral
43 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− Price-to-book of 18.3x prices in significant intangible value
Technical Analyst bullish
69 / 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 18.2% signals elevated volatility
Macro Analyst bullish
78 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst bullish
62 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Open Full Terminal →

Technical Analysis

RSI (14)
60.3
Neutral
MACD Histogram
0.395
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Mixed
Support
$45.28
Resistance
$58.12
Bollinger %B
0.73
Inside Bands
Price vs Moving Averages
EMA 9
$50.68 Above
EMA 21
$50.52 Above
EMA 50
$50.20 Above
EMA 200
$45.93 Above

Fundamental Analysis

Valuation
59
Profitability
0
Financial Health
92
Cash Flow
15
Valuation
P/E Ratio -15.7×
P/B Ratio 26.80×
PEG Ratio 1.44
Dividend Yield 0.00%
52W High $58.49
52W Low $27.07
Quality & Growth
ROE -15395.4%
ROA -9348.6%
Gross Margin 0.0%
Operating Margin 0.0%
Revenue Growth YoY
Debt / Equity 0.80
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of -15.7 (inexpensive relative to a 15-40x range); Price-to-book of 26.8x; PEG ratio of 1.4 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -154.0%; Return on assets of -93.5%; Net margin of 0.0%; Gross margin of 0.0%; Current ratio of 7.02 (healthy short-term liquidity); Debt-to-equity of 0.80; Free cash flow per share is negative (-2.27); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full SRRK Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore SRRK Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime